Cargando…
Sulfatide Deficiency, an Early Alzheimer’s Lipidomic Signature, Causes Brain Ventricular Enlargement in the Absence of Classical Neuropathological Hallmarks
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by progressive memory loss and a decline in activities of daily life. Ventricular enlargement has been associated with worse performance on global cognitive tests and AD. Our previous studies demonstrated that brain sulfatides, my...
Autores principales: | Palavicini, Juan Pablo, Ding, Lin, Pan, Meixia, Qiu, Shulan, Wang, Hu, Shen, Qiang, Dupree, Jeffrey L., Han, Xianlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820719/ https://www.ncbi.nlm.nih.gov/pubmed/36613677 http://dx.doi.org/10.3390/ijms24010233 |
Ejemplares similares
-
Central nervous system sulfatide deficiency as a causal factor for bladder disorder in Alzheimer's disease
por: He, Sijia, et al.
Publicado: (2023) -
Compromised Myelin and Axonal Molecular Organization Following Adult-Onset Sulfatide Depletion
por: Dustin, Elizabeth, et al.
Publicado: (2023) -
Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer’s disease-like neuroinflammation and cognitive impairment
por: Qiu, Shulan, et al.
Publicado: (2021) -
Adult-Onset CNS Sulfatide Deficiency Causes Sex-Dependent Metabolic Disruption in Aging
por: Qiu, Shulan, et al.
Publicado: (2023) -
Myelin lipid deficiency: a new key driver of Alzheimer’s disease
por: Qiu, Shulan, et al.
Publicado: (2022)